Renal dysfunction among anti-retroviral therapy naïve HIV infected patients in Zimbabwe

Cent Afr J Med. 2011 Jan-Apr;57(1-4):1-5.

Abstract

Background: The prevalence and determinants of renal dysfunction among HIV infected adults in the outpatient in Zimbabwe setting is unknown.

Objective: To determine the proportion of patients with evidence of renal dysfunction among anti-retroviral treatment naive HIV infected patients in a tertiary outpatient setting.

Design: Cross sectional study.

Setting: HIV outpatients' clinic (Family Care Centre) at Parirenyatwa hospital.

Subjects: 159 Anti-retroviral therapy (ART) naive HIV infected adults.

Methods: A cross-sectional study was carried out on ART-naive HIV infected willing adult participants, > or = 18 years old. WHO clinical staging was conducted on all participants. Urine was examined using urinary dipsticks and proteinuria quantification by calculating its protein: creatinine ratio. Serum creatinine and CD4 cell counts were measured. Creatinine clearance (CrCl) was calculated using the Cockcroft-Gault formula.

Main outcome measures: The primary endpoint was renal dysfunction defined as CrCl < 60 ml/min. Protenuria, defined as > or = + dipstick positive and/or protein to creatinine ratio > 20 mg/mg was a secondary outcome.

Results: Renal dysfunction defined as CrCl < 60 ml/min was found in 7.5% [95% CI 3.4-11.7] (12/159) of the participants. Risk factors for renal dysfunction were age [OR 1.14, (95% CI 1.06-1.22)], BMI [OR 0.77 (95% CI 0.61-0.94)] andproteinuria [OR 7.45 (95% CI 1.58-35.26)]. Proteinuria was common, occurring in 45.9% of the participants.

Conclusions: [corrected] A high prevalence of proteinuria (45.9%) was found in this study, while the prevalence of reduced creatinine clearance was relatively low (7.5%). Screening for proteinuria is strongly recommended in ART naive HIV infected patients and should be complemented by measurement of serum creatinine and calculation ofcreatinine clearance.

MeSH terms

  • Adult
  • Anti-Retroviral Agents / therapeutic use
  • Creatinine / blood
  • Cross-Sectional Studies
  • Female
  • HIV Infections / complications*
  • HIV Infections / drug therapy
  • HIV Infections / metabolism
  • Humans
  • Kidney Diseases / diagnosis
  • Kidney Diseases / epidemiology*
  • Male
  • Middle Aged
  • Prevalence
  • Urinalysis
  • Zimbabwe

Substances

  • Anti-Retroviral Agents
  • Creatinine